陈峰 + 关注学者
  • 个人主页: 点击访问
  • 所属院系:公共卫生学院
  • 通讯地址:南京市江宁区龙眠大道101号
  • 认领成果数 419
  • wos被引 1,046
  • wos篇均被引 9.26

按条件检索“5”条记录

已选条件:
导出
  • 排序
  • 显示
3. Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population SCIE SCOPUS PubMed 认领

作者:Ma, HX; Xu, L; Yuan, J; Shao, MH; Hu, ZB; Wang, F; Wang, Y; Yuan, WT; Qian, J; Wang, Y; Xun, PC; Liu, HL; Chen, WH; Yang, L; Jin, GF; Huo, X; Chen, F; Shugart, YY; Jin, L; Wei, QY; Wu, TC; Shen, HB; Huang, W; Lu, DR

作者机构:[Ma, HX; Xu, L; Yuan, J; Shao, MH; Hu, ZB; Wang, F; Wang, Y; Yuan, WT; Qian, J; Wang, Y; Xun, PC; Liu, HL; Chen, WH; Yang, L 更多

关键词:Case-control study; DNA repair; Genetic susceptibility; Haplotype; Molecular epidemiology

来源:PHARMACOGENETICS AND GENOMICS,2007,Vol.17,Issue.6

WOS被引频次:16

Scopus被引频次:25

ESI学科:PHARMACOLOGY & TOXICOLOGY

JCR分区:Q1

当年影响因子:5.775

最新一期影响因子:2.184

资源类型:外文期刊论文

5. Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer PubMed SCOPUS SCIE 认领

作者:Ouyang, XN; Shi, MQ; Jie, FW; Bai, YX; Shen, P; Yu, Z; Wang, XW; Huang, C; Tao, M; Wang, ZH; Xie, CH; Wu, Q; Shu, YQ; Han, BH; Zhang, FC; Zhang, YP; Hu, CH; Ma, XT; Liang, YJ; Wang, AL; Lu, B; Shi, Y; Chen, JF; Zhuang, ZX; Wang, JJ; Huang, JJ; Wang, CH; Bai, CX; Zhou, X; Li, Q; Chen, F; Yu, H; Feng, JF

作者机构:[Ouyang, Xuenong; Jie, Fangwei] Fujian Med Univ, Fuzong Clin Coll, Nanjing Mil Command, Dept Med Oncol,Fuzhou Gen Hosp, Fuzhou, Fujian, Peoples R Chin 更多

关键词:Dulanermin; NSCLC; Objective response rate; Phase III; Progression-free survival

来源:INVESTIGATIONAL NEW DRUGS,2018,Vol.36,Issue.2

ESI学科:PHARMACOLOGY & TOXICOLOGY

最新一期影响因子:3.484

资源类型:外文期刊论文

TOP